Taku Yoshida

Also affiliated with Astellas Pharma (Japan), Universal Cells (United States)

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Manipulation of diacylglycerol and ERK-mediated signaling differentially controls CD8+ T cell responses during chronic viral infection”.

Manipulation of diacylglycerol and ERK-mediated signaling differentially controls CD8+ T cell responses during chronic viral infection

Frontiers in Immunology(2022)10.3389/fimmu.2022.1032113

N/A

0DataRank · unranked

7 citations

Omar Khan, Hamid Bassiri, Taku Yoshida, Yohei Okada, Masaomi Takizawa +4 more

The diacylglycerol kinase ζ inhibitor ASP1570 augments natural killer cell function

International Immunopharmacology(2023)10.1016/j.intimp.2023.111145

N/A

0DataRank · unranked

8 citations

Yuichi Yokoyama, Taku Yoshida, Yohei Okada, Masaomi Takizawa, Osamu Ikeda +2 more